Tumor necrosis factor formulations
US5215743A · kind A · utility
53Cited by
8References
13Claims
0Family size
Inventors
Key dates
| Filing date | Apr 13, 1988 |
| Grant date | Jun 1, 1993 |
| Priority date | — |
| Expiry date | Apr 13, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions are described that are suitable for formulating cytokines, preferably tumor necrosis factor, that maintain their biological activities over a wide range of temperatures by, among other aspects, decreasing them sensitivity to agitation, and preventing oligomer and particulate matter formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.